Lv2
140 积分 2026-01-27 加入
Cardiac toxicity of brentuximab vedotin: a real-word disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
1天前
已完结
Sex differences in cardiotoxicity of anaplastic lymphoma kinase inhibitors: An analysis of the FDA Adverse Event Reporting System
1天前
求助中
Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS)
1天前
已完结
Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System
1天前
已关闭
Novel multiple sclerosis agents-associated cardiotoxicity: A real-world pharmacovigilance study
1天前
已完结
Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors
1天前
已完结
Impact of Proton Pump Inhibitors on Osimertinib-Induced Cardiotoxicity in NSCLC Patients
1天前
已完结
Cardiovascular Events Associated with CDK4/6 Inhibitors: A Safety Meta-Analysis of Randomized Controlled Trials and a Pharmacovigilance Study of the FAERS Database
1个月前
已完结
Cardiovascular Events Associated with CDK4/6 Inhibitors: A Safety Meta-Analysis of Randomized Controlled Trials and a Pharmacovigilance Study of the FAERS Database
4个月前
已完结
Cyclin‐dependent kinase 4/6 inhibitors and cardiotoxic events in breast cancer: A pharmacovigilance study based on the FAERS database
4个月前
已完结
皖公网安备34019202002308
